Results
1 -
10 of
105Prognostic factors in recurrent glioblastoma patients treated with bevacizumab, Journal of Neuro-Oncology Effects of exogenous factors on the cerebral glutathione in rodents, Archives of Toxicology Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma, Journal of Neuro-Oncology Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents, Cancer Chemotherapy and Pharmacology Tumorwirksame Medikamente, Onkologische Krankenpflege Chemotherapy: Current Results and Future Prospects, Gliomas Effects of Carmustine and Lomustine on Arylamine N-Acetyltransferase Activity and 2-Aminofluorene-DNA Adducts in Rat Glial Tumor Cells, Neurochemical Research Current Standard Treatment Options for Malignant Glioma, Malignant Brain Tumors Antiangiogenic Therapy for Malignant Gliomas, Malignant Brain Tumors Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine, Clinical and Translational Oncology